S&P 500   4,587.83 (+0.46%)
DOW   34,547.92 (+0.19%)
QQQ   394.06 (+0.06%)
AAPL   167.75 (+1.48%)
MSFT   334.73 (+1.25%)
FB   316.95 (-2.31%)
GOOGL   2,869.26 (+1.10%)
AMZN   3,481.79 (-0.72%)
TSLA   1,130.15 (-1.28%)
NVDA   321.11 (-1.73%)
BABA   124.78 (-2.16%)
NIO   39.35 (+0.56%)
CGC   10.25 (-4.30%)
AMD   151.92 (-4.07%)
GE   94.95 (-0.04%)
MU   86.73 (+3.25%)
T   22.43 (-1.75%)
F   19.87 (+3.54%)
DIS   144.40 (-0.35%)
PFE   54.90 (+2.18%)
ACB   6.16 (-4.05%)
AMC   30.13 (-11.23%)
BA   192.60 (-2.65%)
S&P 500   4,587.83 (+0.46%)
DOW   34,547.92 (+0.19%)
QQQ   394.06 (+0.06%)
AAPL   167.75 (+1.48%)
MSFT   334.73 (+1.25%)
FB   316.95 (-2.31%)
GOOGL   2,869.26 (+1.10%)
AMZN   3,481.79 (-0.72%)
TSLA   1,130.15 (-1.28%)
NVDA   321.11 (-1.73%)
BABA   124.78 (-2.16%)
NIO   39.35 (+0.56%)
CGC   10.25 (-4.30%)
AMD   151.92 (-4.07%)
GE   94.95 (-0.04%)
MU   86.73 (+3.25%)
T   22.43 (-1.75%)
F   19.87 (+3.54%)
DIS   144.40 (-0.35%)
PFE   54.90 (+2.18%)
ACB   6.16 (-4.05%)
AMC   30.13 (-11.23%)
BA   192.60 (-2.65%)
S&P 500   4,587.83 (+0.46%)
DOW   34,547.92 (+0.19%)
QQQ   394.06 (+0.06%)
AAPL   167.75 (+1.48%)
MSFT   334.73 (+1.25%)
FB   316.95 (-2.31%)
GOOGL   2,869.26 (+1.10%)
AMZN   3,481.79 (-0.72%)
TSLA   1,130.15 (-1.28%)
NVDA   321.11 (-1.73%)
BABA   124.78 (-2.16%)
NIO   39.35 (+0.56%)
CGC   10.25 (-4.30%)
AMD   151.92 (-4.07%)
GE   94.95 (-0.04%)
MU   86.73 (+3.25%)
T   22.43 (-1.75%)
F   19.87 (+3.54%)
DIS   144.40 (-0.35%)
PFE   54.90 (+2.18%)
ACB   6.16 (-4.05%)
AMC   30.13 (-11.23%)
BA   192.60 (-2.65%)
S&P 500   4,587.83 (+0.46%)
DOW   34,547.92 (+0.19%)
QQQ   394.06 (+0.06%)
AAPL   167.75 (+1.48%)
MSFT   334.73 (+1.25%)
FB   316.95 (-2.31%)
GOOGL   2,869.26 (+1.10%)
AMZN   3,481.79 (-0.72%)
TSLA   1,130.15 (-1.28%)
NVDA   321.11 (-1.73%)
BABA   124.78 (-2.16%)
NIO   39.35 (+0.56%)
CGC   10.25 (-4.30%)
AMD   151.92 (-4.07%)
GE   94.95 (-0.04%)
MU   86.73 (+3.25%)
T   22.43 (-1.75%)
F   19.87 (+3.54%)
DIS   144.40 (-0.35%)
PFE   54.90 (+2.18%)
ACB   6.16 (-4.05%)
AMC   30.13 (-11.23%)
BA   192.60 (-2.65%)

Is 3M (NYSE: MMM) Earnings Beat the Start of a New Rally?

Wednesday, January 27, 2021 | Nick Vasco
Is 3M (NYSE: MMM) Earnings Beat the Start of a New Rally?3M (NYSE: MMM) released its fourth-quarter numbers yesterday, and beat on the top and bottom lines. Shares gained more than 3% on high volume, and neared the $180 level, where 3M has faced resistance since last summer.

So, does 3M have what it takes to break through? Or are shares going to head back down to around $160?

Let’s start by digging into the Q4 numbers:

3M reported revenue of $8.6 billion in Q4, up 5.8% yoy and above analyst estimates of $8.4 billion. EPS came in at $2.38, up 43% yoy and above Wall Street estimates of $2.15.

The company’s safety and industrial business saw organic growth of 11.4% yoy in Q4. According to management, pandemic-related respirator mask demand provided a 10-percentage point benefit to the growth rate.

Insufficient mask production was one of the biggest issues in the early stages of the pandemic. But 3M has done an incredible job of increasing capacity. On the Q4 earnings call, CEO Mike Roman talked on that: “In total, last year (2020), we produced and delivered 2 billion respirators globally, with approximately half in the United States. Today, we are at an annual run rate of 2.5 billion respirators, a fourfold increase versus 2019.”

Roman also pointed out “sequential improvement” in the automotive OEM segment. This segment was a weak spot in Q2, so it’s encouraging to see sales trending in the right direction.

Another weak spot in Q2 was health care; 3M’s oral care business was down 60% yoy in Q2 due to delays in elective procedures. But the oral care business has bounced back over the last two quarters. In Q3, it was up low-single digits “driven by the reopening of dental offices globally and the rebuild of channel inventories.” In Q4, the oral care business’s organic sales were flat yoy. 3M said that rising COVID cases prevented the business from growing, but still, flat is a heck of a lot better than down 60%.

Guidance Wasn’t Great, But It’s Better Than Nothing

3M is forecasting 2021 EPS of between $9.20 and $9.70 per share. The $9.45 midpoint was 7 cents per share shy of the average analyst estimate of $9.52 per share. It is, however, higher than the $8.74 in EPS for full-year 2020.

Ideally, 3M’s forecast would have come in above what Wall Street was expecting, but simply offering guidance is more than a lot of industrial companies are willing to do in the current environment. Moreover, 3M is probably erring on the side of caution with its estimates, and earnings could quite possibly come in at the higher end of the range. Or more.

What About Polyfluoroalkyl Substances?

Ah, polyfluoroalkyl substances (PFAS). For those who have never heard of PFAS, it’s a chemical that has caused water contamination. How does this relate to 3M?

The company used the chemical until the early 2000s, and it still facing litigation today. 3M recorded a $752 million liability charge against earnings in 2019 to account for it, but that may not be the final amount. With Democrats now controlling the presidency and both houses of Congress, some investors are spooked.

3M addressed the liability on its Q4 call, saying that its “corporate and unallocated expense was up approximately $100 million yoy.” But that expense accounts for not just the PFAS liability but also the company’s “respirator mask reserve.”

Here’s the deal:

Even if the final amount is higher than $752 million, it probably won’t be much higher. 3M has a market cap of around $100 billion. That $752 million is less than 1% of the company’s market cap. So, the settlement is unlikely to impact the viability of a 3M investment.

3M Shares Could Be Headed Higher

 3M has successfully navigated the pandemic, increasing mask production and turning around struggling segments. Furthermore, the company looks set for modest growth over the next two years.

At 18.5x forward earnings, you can get that growth at a reasonable price. Another thing you can get is an outstanding dividend. 3M’s dividend is 3.34% and has been increased every year for more than 60 years. The company’s 68% payout ratio is a bit high, but future earnings should be able to easily support further increases.

Bottom line: there’s a good chance that 3M breaks through the $180 level in the near future.

Is 3M (NYSE: MMM) Earnings Beat the Start of a New Rally?

Should you invest $1,000 in 3M right now?

Before you consider 3M, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and 3M wasn't on the list.

While 3M currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
3M (MMM)2.9$173.07+1.8%3.42%16.98Hold$194.00
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.